SRx Health Solutions, Inc.

SRx Health Solutions, Inc. is a U.S.-listed healthcare and consumer products company with operations centered in Canada. Its business has included specialty pharmacies, specialty health clinics, clinical trial sites, pharmaceutical wholesale and distribution, and pet health and wellness products sold under the Halo brand.

10

0.80

0.69

— SRx Health Solutions, Inc.
%
Specialty pharmacy35% Dispensing and managing high-complexity medications for chronic, rare, and specialty conditions.
Clinical services20% Infusion clinics, allied health, nursing, and patient support services tied to specialty therapies.
Wholesale distribution15% Pharmaceutical distribution and logistics services supporting pharmacies and care sites.
Clinical research5% Clinical trial site operations and related research support services.
Consumer pet products25% Halo-branded premium and super-premium pet food and wellness products sold through multiple channels.

SRx Health serves patients with chronic, rare, and other specialty conditions who need complex medications, clinical...

  • Specialty therapy patientsprimary

    Patients needing complex medications, infusion support, and adherence services for chronic or rare diseases.

  • Healthcare providers and care teamsprimary

    Physicians, pharmacists, nurses, and clinics that refer, administer, or coordinate specialty care.

  • Pharmaceutical manufacturers and distributorssecondary

    Partners that rely on SRx for dispensing, logistics, patient support, and access to specialty therapies.

  • Pet product consumersprimary

    Households purchasing Halo pet food and wellness products through digital, international, and retail channels.

  • Clinical research sponsorsemerging

    Organizations using clinical trial sites for patient recruitment and study execution.

SRx Health’s healthcare network is concentrated in Canada, with operations spanning all ten provinces and a...

  • Operations span all ten Canadian provinces
  • Wholesale/distribution facility in Mississauga, Ontario
  • Specialty pharmacy and clinic network across Canada
  • Consumer products sold through digital and international channels
  • Canadian regulatory and logistics footprint is central to service delivery

SRx Health’s stated focus is to simplify access to complex therapies through an integrated Canadian specialty...

01
Stabilize the continuing businessshort-term

A narrower operating base requires disciplined execution and continuity in core channels.

02
Build around the Halo consumer platformshort-term

Consumer products provide the continuing revenue base and a simpler commercial model.

03
Pursue targeted partnerships and product expansionmedium-term

Partnerships and new products can extend reach without recreating the prior capital-heavy model.

SRx Health faces operational risk from distribution interruptions, inventory mismanagement, and dependence on...

high

Distribution facility disruption

The business depends on orderly receiving and distribution to supply pharmacies and customers.

Scope
Pharmaceutical distribution and fulfillment
Materiality
high
high

Inventory mismanagement

Demand shifts or poor forecasting can leave excess or obsolete inventory.

Scope
Consumer products and distributed products
Materiality
high
high

Regulatory and compliance risk

Specialty pharmacy, clinics, and distribution operate in a heavily regulated environment.

Scope
Healthcare operations
Materiality
high
medium

Third-party technology dependence

Interoperability with external networks, devices, and data sources can affect service performance.

Scope
Healthcare technology and service delivery
Materiality
medium
medium

Reputation and supplier quality risk

Brand damage at suppliers or manufacturers can spill over to SRx products and customer trust.

Scope
Consumer products
Materiality
medium
Revenue recognition and returns
Affects reported net sales and gross margin presentation
Share-based compensation
Affects operating expenses and diluted earnings
Goodwill and intangible impairment
Can create material non-cash charges
Asset recoverability and estimates
Can affect balance sheet values and earnings

: 29.4.2026